Acne has one of dermatology's better-mapped treatment evidence bases: a 2018 network meta-analysis ranked benzoyl peroxide and combination regimens among the most effective topical agents, and trials consistently assessed results at 12 weeks. Roughly 85 percent of people between 12 and 24 experience acne, per National Institutes of Health estimates.
Newspaper Daily publishes information, not medical advice. This article reviews what studies report about acne treatments; it does not diagnose acne severity or recommend prescription therapy, decisions that belong with a clinician who can examine the skin.
What does over-the-counter evidence support?
Four ingredients carry most of the nonprescription evidence:
- Benzoyl peroxide: randomized trials across decades show meaningful reductions in inflammatory lesions at 2.5 to 10 percent, with lower concentrations working about as well with less dryness. It also reduces Cutibacterium acnes bacteria, and, importantly for drug resistance, no bacterial resistance to it develops.
- Adapalene 0.1 percent: the FDA approved this retinoid for nonprescription sale in 2016 after trials showed significant lesion reductions at 12 weeks. Retinoids address comedones, the clogged pores where acne begins.
- Salicylic acid: trials show modest comedone and inflammatory lesion improvement at 0.5 to 2 percent, generally smaller than benzoyl peroxide effects.
- Azelaic acid: available over the counter up to 10 percent in the United States, with trial support for both lesions and post-acne dark marks.
Realistic timelines matter in trials: most measure outcomes at 12 weeks, and improvement begins around four to eight weeks. Abandoning a treatment at three weeks predates when studies say change becomes measurable.
How do the main over-the-counter ingredients compare?
Trials differ in design, so the table reflects general directions from the literature rather than precise rankings.
| Ingredient | Strength studied | Best-supported role | Common limitation |
|---|---|---|---|
| Benzoyl peroxide | 2.5 to 10 percent | Inflammatory lesions | Bleaching fabrics; dryness |
| Adapalene 0.1 percent | 0.1 percent gel | Comedones and maintenance | Slow onset; adjustment irritation |
| Salicylic acid | 0.5 to 2 percent | Mild comedonal acne | Smaller effect sizes in trials |
| Azelaic acid | 10 percent OTC; 15 to 20 percent prescription | Lesions plus dark marks | Tingling during first weeks |
Reviewers also note that combining ingredients with different mechanisms, such as a retinoid at night and benzoyl peroxide in the morning, outperforms single-ingredient routines in comparative trials, provided the total irritation load stays manageable.
Which prescription options do trials support?
Dermatology reviewers describe several well-studied prescription paths. Topical retinoids tretinoin and tazarotene have decades of trial data for comedonal and inflammatory acne. Topical clindamycin and erythromycin work modestly alone but perform better combined with benzoyl peroxide, a pairing trials showed limits antibiotic resistance. Oral options studied in randomized trials include doxycycline-class antibiotics for moderate disease, spironolactone for adult female hormonal-pattern acne in multiple studies and a 2017 primary-care trial, and isotretinoin for severe nodular acne, where trials report long-term remission in a majority of patients under an FDA risk-management program because of teratogenic risk. Hormonal therapies including combined oral contraceptives have randomized-trial support for acne in women.
Prescribing decisions weigh severity, scarring risk, and individual factors; the studies above describe what regulators have approved and what trials measured, not a self-treatment guide.
Related stories: Vitamin C Serums: What the Evidence Shows · Retinoids for Skin: What the Evidence Actually Supports.
Does diet or hygiene cause acne?
The hygiene theory has little support: studies find no meaningful association between face-washing frequency and acne severity, and over-washing worsens irritation. Diet evidence is emerging but limited; a 2018 meta-analysis associated high glycemic-load diets with more acne, and some observational studies link skim milk with breakouts, though randomized diet-intervention trials are few and small. Professional guidelines describe diet as a possible modifier for some people rather than a treatment in itself.
What about popular home and natural remedies?
Evidence here thins out quickly. Tea tree oil has small trials showing modest anti-acne effects at 5 percent with slower onset than benzoyl peroxide. For pore strips, toothpaste, lemon juice, apple cider vinegar, and most social-media remedies, published controlled evidence is absent or negative, and several, including undiluted acids and toothpaste, are documented causes of irritation and contact dermatitis in case reports. Natural origin, as dermatology reviewers note, is not an efficacy category.
Does makeup or sweating make acne worse?
Comedogenicity ratings have a weak evidence base; controlled comparisons of cosmetic products found modern noncomedogenic labels only partially predict pore-clogging in testing. What trials better support is removal habits and friction: studies of athletes show acne mechanica, friction-driven breakouts, where equipment contacts skin. Small studies suggest oil-free, noncomedogenic sunscreen and makeup choices reduce flares in acne-prone skin, though head-to-head product trials are scarce.
Do spot treatments and patches work?
Hydrocolloid patches physically absorb fluid and protect lesions from picking, and small studies of medicated patches containing salicylic acid reported modest single-lesion improvement, but no published trial supports the dramatic overnight results shown in advertising. Spot treatment in general has a structural limitation: trials consistently show that treating the whole acne-prone area prevents new lesions better than chasing individual spots, because comedones form days before they become visible.
What about scarring and dark marks?
Treating acne early is itself the main anti-scarring strategy in reviews, since deep inflammation drives scar formation. Post-inflammatory hyperpigmentation, common and more persistent in deeper skin tones, usually fades over months once inflammation is controlled; trials of azelaic acid, retinoids, and niacinamide show support for accelerating that fade. Picking and squeezing lesions is associated in observational studies with worsened scarring.
What about adult acne?
Acne is not only adolescent: dermatology clinic surveys report acne affecting a substantial share of women into their thirties and beyond, often along the jawline and flaring cyclically. Trials specific to adult female acne, including studies of spironolactone and hormonal therapies, have grown since the mid-2010s and support distinct treatment pathways. Adult skin also tolerates aggressive drying regimens worse, which is why studies in this population frequently pair active treatment with barrier-supporting moisturizers.
When should someone see a dermatologist?
Professional care is warranted when acne is moderate to severe, nodular, or leaving scars; when over-the-counter treatment shows no measurable benefit after about 12 weeks; when adult-onset acne suggests a hormonal pattern; when acne appears alongside irregular periods or excess hair growth, which can accompany polycystic ovary syndrome; and whenever breakouts carry significant psychological weight, which studies link with depression risk comparable to other chronic conditions. Clinicians can also confirm the diagnosis, since rosacea and folliculitis mimic acne and respond to different treatment.
Bottom line
The acne evidence base favors unglamorous consistency: benzoyl peroxide and adapalene for nonprescription care, combination prescription regimens for moderate disease, and isotretinoin for severe cases, with results measured in months. Home remedies and hygiene obsession lack comparable support, and early treatment is the best documented defense against scarring.